基于影像的FFR诊断市场规模、份额和成长分析：按技术类型、应用领域、最终用户和地区划分－2026-2033年产业预测

2024年全球基于影像的FFR诊断市场价值为8.118亿美元，预计将从2025年的8.4995亿美元增长到2033年的12.2735亿美元。预测期（2026-2033年）的复合年增长率预计为4.7%。

全球基于影像的FFR诊断市场需求旺盛，其驱动力在于对非侵入性血流动力学评估的需求，旨在提高临床决策的准确性。此方法结合了冠状动脉CT血管摄影检查和计算流体力学，能够估算动脉病变处的压力梯度，使医师无需进行有创导管介入即可有效分诊患者。这种方法显着降低了手术风险和成本，有助于医院更快地采用该方法，并改善患者预后。影像技术和人工智慧的进步极大地提高了诊断准确性，增强了临床医生的信心，并加速了临床应用。将这些解决方案整合到现有工作流程中，并减少不必要的侵入性手术，有助于获得保险公司的报销支持，并为可扩展平台的开发创造机会。这一趋势在新兴市场尤为有利，因为这些市场对先进诊断成像的需求正在不断增长。

全球基于影像的FFR诊断市场驱动因素

全球基于影像的FFR诊断市场正在成长，这主要得益于临床工作流程效率的提高以及透过与传统影像设备无缝整合而增强的诊断信心。这种相容性实现了与导管检查室系统的流畅资料传输和同步，最终最大限度地降低了手术复杂性和工作流程中断。由于临床医生可以轻鬆地将这些先进技术整合到现有诊疗实践中，其应用潜力正在不断扩大。这些系统的使用者友善性及其在介入治疗过程中提升决策能力的能力，正在降低临床应用门槛，并促使各种医疗机构的需求不断增长。

全球基于影像的FFR诊断市场限制因素

由于临床医生对这些创新技术的认知度和熟悉度较低，基于影像的FFR诊断的全球市场面临着许多限制因素。这种认知不足导致医疗服务提供者和管理者犹豫不决，使他们更倾向于采用现有的侵入性方法，而非那些可能被认为存在不确定性或颠覆性的新方法。此外，由于医疗机构往往优先考虑其他项目而非技能发展的投资，教育和培训计画的需求也面临进一步的挑战。因此，知识传播缓慢以及临床实践中保守的文化阻碍了这些技术的应用，限制了供应商和医院之间的合作，并最终导致市场成长缓慢，最终回归传统治疗路径。

基于影像的FFR诊断的全球市场趋势

全球基于影像的FFR诊断市场正经历着向人工智慧增强型诊断工作流程的重大转变，这主要得益于临床医生越来越多地采用机器学习模型来优化影像解读和简化工作流程。这一趋势的驱动力源于对提高诊断准确性、减少操作者差异以及增强医疗团队决策支援的需求。供应商正优先开发可解释的人工智慧、与PACS系统的无缝整合以及先进的使用者介面，以增强临床医生的信心并提高易用性。随着人工智慧能力的不断发展，跨学科协作和工作流程客製化对于其在临床上的广泛应用和营运效率的提升至关重要。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球基于影像的FFR诊断市场规模：按技术类型和复合年增长率划分（2026-2033年）

• CT血管摄影检查
• MRI
• X光影像诊断
• 其他的

全球基于影像的FFR诊断市场规模：按应用和复合年增长率划分（2026-2033年）

• 冠状动脉疾病
• 周边动脉疾病
• 结构性心臟疾病
• 其他的

全球基于影像的FFR诊断市场规模：按技术类型和复合年增长率划分（2026-2033年）

• 软体解决方案
• 医疗影像设备
• 数据分析工具
• 其他的

全球基于影像的FFR诊断市场规模：按最终用户和复合年增长率划分（2026-2033年）

• 医院
• 诊断中心
• 研究机构
• 其他的

全球基于影像的FFR诊断市场规模及复合年增长率（2026-2033年）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• HeartFlow
• Siemens Healthineers
• Philips Healthcare
• Abbott Laboratories
• GE Healthcare
• Terumo Corporation
• Acist Medical Systems
• Canon Medical Systems
• Toshiba Medical Systems
• Biotronik
• Medtronic
• Cardiologs
• Aceso Diagnostics
• Quantib
• Bracco Imaging
• Fujifilm Medical
• Stryker Corporation
• Cardiovascular Systems Inc.
• Optellum
• Imbio

结论与建议

Global Image-Based Ffr Diagnosis Market size was valued at USD 811.8 Million in 2024 and is poised to grow from USD 849.95 Million in 2025 to USD 1227.35 Million by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global image-based FFR diagnosis market is driven by the need for noninvasive hemodynamic assessments to enhance clinical decision-making. Utilizing coronary CT angiography combined with computational fluid dynamics, this method estimates pressure gradients across arterial lesions, allowing physicians to effectively triage patients without the need for invasive catheterization. This approach significantly reduces procedural risks and costs, promoting hospital adoption and improving patient outcomes. Enhanced imaging technologies and AI advancements have markedly increased diagnostic accuracy, leading to greater clinician confidence and fostering wider acceptance in clinical practice. The integration of these solutions into established workflows, coupled with a reduction in unnecessary invasive procedures, is encouraging payers to support reimbursement, thereby creating opportunities for scalable platforms. This trend is particularly beneficial in emerging markets where the demand for advanced imaging is on the rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Image-Based Ffr Diagnosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Image-Based Ffr Diagnosis Market Segments Analysis

Global image-based ffr diagnosis market is segmented by technique type, application area, technology type, end user and region. Based on technique type, the market is segmented into CT Angiography, MRI, X-ray Imaging and Others. Based on application area, the market is segmented into Coronary Artery Disease, Peripheral Artery Disease, Structural Heart Conditions and Others. Based on technology type, the market is segmented into Software Solutions, Imaging Equipment, Data Analysis Tools and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Centers, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Image-Based Ffr Diagnosis Market

The Global Image-Based FFR Diagnosis market is experiencing growth driven by the seamless integration of image-based systems with traditional imaging modalities, leading to enhanced clinical workflow efficiency and increased diagnostic confidence. This compatibility facilitates smooth data transfer and synchronization with catheterization lab systems, ultimately minimizing procedural complexity and workflow disruption. As clinicians find it easier to incorporate these advanced technologies into their established practices, the likelihood of adoption rises. The user-friendly nature of these systems and their ability to improve decision-making during interventions contribute to lowered barriers for clinical adoption, resulting in heightened demand across various healthcare environments.

Restraints in the Global Image-Based Ffr Diagnosis Market

The global image-based FFR diagnosis market faces significant restraints due to limited clinical awareness and familiarity with these innovative technologies. This lack of exposure can create reluctance among healthcare providers and administrators, leading them to favor established invasive methods over newer approaches, which they may view as uncertain or disruptive. The necessity for education and training programs poses additional challenges, as institutions often prioritize competing initiatives over investment in skill development. Consequently, slow dissemination of knowledge and conservative cultures within clinical practices hinder the adoption of these technologies, restrict collaboration between vendors and hospitals, and ultimately slow the market's growth into conventional care pathways.

Market Trends of the Global Image-Based Ffr Diagnosis Market

The Global Image-Based FFR Diagnosis market is witnessing a significant shift towards AI-enhanced diagnostic workflows, as clinicians embrace machine learning models to optimize image interpretation and streamline workflows. This trend is driven by the need for improved diagnostic confidence, reduction of variability among operators, and enhanced decision support for care teams. Vendors are prioritizing the development of explainable AI, seamless integration with PACS systems, and refined user interfaces to foster clinician trust and usability. As AI capabilities evolve, the focus on cross-disciplinary collaboration and customization of workflows is becoming essential for achieving widespread clinical adoption and enhancing operational efficiency.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Image-based FFR Diagnosis Market Size by Technique Type & CAGR (2026-2033)

• Market Overview
• CT Angiography
• MRI
• X-ray Imaging
• Others

Global Image-based FFR Diagnosis Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease
• Structural Heart Conditions
• Others

Global Image-based FFR Diagnosis Market Size by Technology Type & CAGR (2026-2033)

• Market Overview
• Software Solutions
• Imaging Equipment
• Data Analysis Tools
• Others

Global Image-based FFR Diagnosis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Research Institutions
• Others

Global Image-based FFR Diagnosis Market Size & CAGR (2026-2033)

• North America (Technique Type, Application Area, Technology Type, End User)
  • US
  • Canada
• Europe (Technique Type, Application Area, Technology Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technique Type, Application Area, Technology Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technique Type, Application Area, Technology Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technique Type, Application Area, Technology Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• HeartFlow
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acist Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiologs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aceso Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantib
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optellum
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imbio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations